--- title: "Prestige Consumer Healthcare (PBH) news: offering" url: "https://aibio.space/companies/prestige-consumer-healthcare/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "PBH offering news: Prestige Consumer Healthcare draws $95.0 million term loan to fund LaCorium acquisition. Prestige Consumer Healthcare Inc." --- PBH Prestige Consumer Healthcare Inc. NYSE · United States # Prestige Consumer Healthcare (PBH) news PBH offering news Debt Financing · 2026-07-15 ## [Prestige Brands sells $400.0 million of 6.250% senior notes due 2034](https://aibio.space/news/prestige-brands-sells-400-0-million-6-250-percent-senior-notes-due/) Prestige Brands, a subsidiary of Prestige Consumer Healthcare, issued $400.0 million of 6.250% senior notes due 2034. The 8-K names no placement agent, underwriter or advisor and does not say how the proceeds will be used. The parent's annual report says Walmart and Amazon were its only customers above 10% of gross revenues during 2026. ## Latest Prestige Consumer Healthcare news 1. 2026-07-06 Debt Financing [Prestige Consumer Healthcare draws $95.0 million term loan to fund LaCorium acquisition](https://aibio.space/news/prestige-consumer-healthcare-draws-95-0-million-term-loan-fund/) The company's subsidiary drew $95,000,000 on July 1, 2026. The 8-K also notes a $400,000,000 private offering of senior unsecured notes due 2034 whose pricing a July 6, 2026 press release announced. 2. 2026-06-16 Mergers [Prestige Consumer Healthcare closes $1.045 billion Breathe Right acquisition, signs new term loan](https://aibio.space/news/prestige-consumer-healthcare-closes-1-045-billion-breathe-right/) Prestige Consumer Healthcare (NYSE: PBH) completed the Breathe Right purchase for $1.045 billion in cash and entered a Term Loan Credit Agreement. It also raised its asset-based revolver commitments to $225 million. ## Prestige Consumer Healthcare at a glance - **Ticker**: PBH - **Listing**: NYSE - **Country**: United States - **Cash, Jun 30, 2026**: $89.1 million ### Related companies - [Bristol-Myers Squibb](https://aibio.space/companies/bristol-myers-squibb/) NYSE: BMY - [Arcturus Therapeutics Holdings](https://aibio.space/companies/arcturus-therapeutics/) NASDAQ: ARCT - [Actuate Therapeutics](https://aibio.space/companies/actuate-therapeutics/) NASDAQ: ACTU - [Amphastar Pharmaceuticals](https://aibio.space/companies/amphastar-pharmaceuticals/) NASDAQ: AMPH - [Quoin Pharmaceuticals](https://aibio.space/companies/quoin-pharmaceuticals/) NASDAQ: QNRX - [ZyVersa Therapeutics](https://aibio.space/companies/zyversa-therapeutics/) OTC: ZVSA - [Praxis Precision Medicines](https://aibio.space/companies/praxis-precision-medicines/) NASDAQ: PRAX - [Ernexa Therapeutics](https://aibio.space/companies/ernexa-therapeutics/) NASDAQ: ERNA ### Also on NYSE - [Goldman Sachs Group](https://aibio.space/companies/goldman-sachs/) GS - [InfuSystem Holdings](https://aibio.space/companies/infusystem/) INFU - [Penumbra](https://aibio.space/companies/penumbra/) PEN - [SHOULDER INNOVATIONS, INC.](https://aibio.space/companies/shoulder-innovations/) SI - [AMERICAN SHARED HOSPITAL SERVICES](https://aibio.space/companies/american-shared-hospital-services/) AMS - [Butterfly Network](https://aibio.space/companies/butterfly-network/) BFLY ## What Prestige Consumer Healthcare does Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of brand name over-the-counter health and personal care products in North America, Australia and certain other international markets. It conducts operations in two reportable segments, North American OTC Healthcare and International OTC Healthcare, and its fiscal year ends March 31. Its major brands include Chloraseptic sore throat products, Monistat vaginal anti-fungal treatments, Fleet adult enemas and suppositories, Gaviscon upset stomach remedies, Dramamine motion sickness relief, Compound W wart removal and Nix lice treatments. Its International segment includes Fess nasal saline sprays and Hydralyte oral rehydration products, with the Fess and Hydralyte data for the Australian market. Major brands accounted for approximately 83.5% of total revenues for 2026. The company has grown its portfolio through acquisitions and organic growth, and sells through mass merchandisers, drug and drug wholesale, food, dollar, convenience and club stores and e-commerce channels. | Product or program | What it is | Stage | |---|---|---| | Chloraseptic | Sore throat sprays and lozenges | | | Monistat | Vaginal anti-fungal treatment for yeast infections | | | Fleet | Adult enemas and suppositories | | | Gaviscon | Upset stomach remedy that forms a protective foam barrier | | | Dramamine | Motion sickness relief | | | Compound W | Wart removal treatment | | Summarised from the company's [10-K filed May 14, 2026](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/pbh-20260331.htm). ## Prestige Consumer Healthcare annual financials | Line | FY ended Mar 31, 2026 | FY ended Mar 31, 2025 | |---|---|---| | Net income (loss) | [$190.3 million](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/) | [$214.6 million](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/) | | Cash from operations | [$257.6 million](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/) | [$251.5 million](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/) | | Cash and equivalents | [$63.9 million](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000042/) | [$97.9 million](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $89.1 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Prestige Consumer Healthcare Has Prestige Consumer Healthcare raised money recently? Our latest story on this, dated Jul 6, 2026: "Prestige Consumer Healthcare draws $95.0 million term loan to fund LaCorium acquisition". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/prestige-consumer-healthcare-draws-95-0-million-term-loan-fund/). What is the ticker symbol of Prestige Consumer Healthcare? Prestige Consumer Healthcare Inc. trades under the ticker PBH on NYSE. Where is Prestige Consumer Healthcare listed? Prestige Consumer Healthcare Inc. is listed on NYSE. What is the SEC CIK of Prestige Consumer Healthcare? The SEC Central Index Key (CIK) for Prestige Consumer Healthcare Inc. is 1295947. Its filings are on SEC EDGAR. How many shares does Prestige Consumer Healthcare have outstanding? 47,374,522 shares as of 2026-07-31, per the cover page of its 10-Q filed 2026-08-06. Which country or territory is Prestige Consumer Healthcare listed under? Our directory records Prestige Consumer Healthcare Inc. under United States. What does Prestige Consumer Healthcare do? Our directory classifies Prestige Consumer Healthcare Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Prestige Consumer Healthcare? The ISIN recorded for Prestige Consumer Healthcare Inc. is US74112D1019. Does aibio.space cover Prestige Consumer Healthcare? aibio.space lists Prestige Consumer Healthcare Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What does Prestige Consumer Healthcare develop? Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of brand name over-the-counter health and personal care products in North America, Australia and certain other international markets. It conducts operations in two reportable segments, North American OTC Healthcare and International OTC Healthcare, and its fiscal year ends March 31. What is Chloraseptic from Prestige Consumer Healthcare? Chloraseptic: Sore throat sprays and lozenges What is Monistat from Prestige Consumer Healthcare? Monistat: Vaginal anti-fungal treatment for yeast infections Is Prestige Consumer Healthcare profitable? Prestige Consumer Healthcare Inc. reported net income of $190.3 million for the fiscal year ended Mar 31, 2026, and generated $257.6 million of cash from operations, per its annual report to the SEC. How much cash does Prestige Consumer Healthcare have? $89.1 million in cash at Jun 30, 2026, per its 10-Q. What is the latest Prestige Consumer Healthcare (PBH) stock news? Our latest story on Prestige Consumer Healthcare, dated Jul 15, 2026: "Prestige Brands sells $400.0 million of 6.250% senior notes due 2034". Prestige Brands, a subsidiary of Prestige Consumer Healthcare, issued $400.0 million of 6.250% senior notes due 2034. The 8-K names no placement agent, underwriter or advisor and does not say how the proceeds will be used. The parent's annual report says Walmart and Amazon were its only customers above 10% of gross revenues during 2026. [Source](https://aibio.space/news/prestige-brands-sells-400-0-million-6-250-percent-senior-notes-due/). ## Investor discussion: Prestige Consumer Healthcare Members talk about Prestige Consumer Healthcare (PBH). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Prestige Consumer Healthcare, newest first. Each line links the filing it comes from. 1. 2026-06-16 Mergers Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 1.01,2.01,2.03,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1295947/000110465926074259/tm2618021d1_ex99-1.htm) 2. 2026-05-13 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,2.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000013/exhibit991fy26-q4earningsr.htm) 3. 2025-08-07 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,2.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1295947/000129594725000027/exhibit991fy26-q1earningsr.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:PBH on TradingView](https://www.tradingview.com/symbols/NYSE-PBH/). ## SEC filings and registration - **SEC name**: Prestige Consumer Healthcare Inc. - **CIK**: 1295947 - **Industry (SIC)**: Pharmaceutical Preparations (2834) - **US tickers**: PBH (NYSE) - **Fiscal year ends**: March 31 - **Filer category**: Large accelerated filer - **Business address**: 660 WHITE PLAINS RD., TARRYTOWN, NY, 10591 - **Phone**: (914) 524-6800 - **Shares outstanding**: 47,374,522 as of 2026-07-31 (10-Q filed 2026-08-06) - **Former names**: Prestige Brands Holdings, Inc. ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000049/pbh-20260810.htm) filed 2026-08-14 - [10-Q](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000042/pbh-20260630.htm) filed 2026-08-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000040/pbh-20260806.htm) filed 2026-08-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1295947/000110465926083872/tm2620415d1_8k.htm) filed 2026-07-15 - [8-K](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000029/pbh-20260630.htm) filed 2026-07-06 - [DEF 14A](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000021/pbh-20260625.htm) filed 2026-06-29 - [8-K](https://www.sec.gov/Archives/edgar/data/1295947/000110465926074259/tm2618021d1_8k.htm) filed 2026-06-16 - [10-K](https://www.sec.gov/Archives/edgar/data/1295947/000129594726000016/pbh-20260331.htm) filed 2026-05-14 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001295947), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Prestige Consumer Healthcare Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker PBH, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Prestige Consumer Healthcare Inc. - **Ticker**: PBH - **Listing**: NYSE - **Country or territory**: United States - **Business scope**: Pharmaceuticals: Major - **ISIN**: US74112D1019 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NYSE-PBH/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/prestige-consumer-healthcare/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Prestige Consumer Healthcare (PBH) news: offering", 2026-10-31, https://aibio.space/companies/prestige-consumer-healthcare/